Market Insights Health Pharmacies OTC Products

Skin Treatment (Pharmacies) - Ireland

Ireland

Revenue in the Skin Treatment market is projected to reach US$18.80m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 3.52%, resulting in a market volume of US$21.59m by 2028.
In global comparison, most revenue will be generated in the United States (US$3,319.00m in 2024).
In relation to total population figures, per person revenues of US$3.69 are generated in 2024.

Key regions: Canada, United States, France, Europe, United Kingdom

Market

Region

Region comparison

Currency

Analyst Opinion

The Skin Treatment (Pharmacies) market in Ireland has experienced significant growth in recent years, driven by changing customer preferences and local special circumstances.

Customer preferences: Customers in Ireland are increasingly prioritizing skincare and are willing to invest in high-quality products to address their skin concerns. This shift in preference can be attributed to several factors, including the growing awareness of the importance of skincare and the influence of social media and beauty influencers. Consumers are seeking products that are effective, safe, and tailored to their specific skin types and concerns. They are also showing a preference for natural and organic skincare products, as well as those that are cruelty-free and environmentally friendly.

Trends in the market: One of the key trends in the Skin Treatment (Pharmacies) market in Ireland is the rise of multi-step skincare routines. Customers are adopting skincare rituals that involve multiple products, such as cleansers, toners, serums, moisturizers, and masks. This trend is driven by the belief that a comprehensive skincare routine can deliver better results and address multiple skin concerns. As a result, there is a growing demand for skincare products that can be easily incorporated into these routines. Another trend in the market is the increasing popularity of anti-aging skincare products. With an aging population, there is a growing demand for products that can help reduce the signs of aging, such as wrinkles, fine lines, and age spots. Customers are seeking products with ingredients like retinol, hyaluronic acid, and peptides, which are known for their anti-aging properties. Additionally, there is a rising interest in preventive skincare, with younger customers starting to use anti-aging products as a proactive measure.

Local special circumstances: Ireland's climate and environmental conditions also play a role in shaping the Skin Treatment (Pharmacies) market. The country's temperate and often damp climate can lead to specific skin concerns, such as dryness, sensitivity, and acne. As a result, customers in Ireland are more likely to seek products that can address these specific issues. Additionally, the prevalence of fair skin in the population has led to a higher demand for sun protection products, including sunscreen and moisturizers with SPF.

Underlying macroeconomic factors: The growing Skin Treatment (Pharmacies) market in Ireland is also influenced by underlying macroeconomic factors. The country's strong economy and rising disposable incomes have contributed to increased consumer spending on skincare products. Additionally, the presence of a well-developed pharmacy sector in Ireland ensures easy access to a wide range of skincare products. The pharmacy channel is trusted by customers, who often seek advice from pharmacists on skincare concerns and product recommendations. In conclusion, the Skin Treatment (Pharmacies) market in Ireland is experiencing growth due to changing customer preferences, including a focus on skincare, multi-step routines, and anti-aging products. The local climate and environmental conditions also contribute to specific skincare needs, while the strong economy and well-developed pharmacy sector support the market's expansion.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.